IRCT201009154755N1已完成未知
Assigning the effect of administration of cabergoline on uterine perfusion in women with polycystic ovary syndrome
Kurdistan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 55 years（—）
- 性别
- Female
入选标准
- •age 20 years, living in Sanandaj
- •Exclusion criteria: pregnancy, breastfeeding, contraindication or adverse effects of cabergoline (nausea, vomiting, visual disturbances)
排除标准
- 未提供
研究者
相似试验
尚未招募
Unknown
Comparison of the effect of Cabergoline versus Dienogest on markers in endometriosisCTRI/2023/04/051886il
招募中
2 期
Cabergolin effect on IVF for endometriosisIRCT20091012002576N35Tehran University of Medical Sciences200
尚未招募
Unknown
To study the benefits of addition of Cabergoline to Metformin in women with PCOSCTRI/2024/08/071776il
已完成
3 期
Treatment of uterine myoma.fibromyoma of uterus.Leiomyoma of uterusfibromyoma of uterusIRCT201403092624N12Vice chancellor for research ,Iran University of Medical Sciences.50
招募中
3 期
The effects of cabergoline in reducing the size of endometriomaIRCT20150817023666N9Iran University of Medical Sciences32